BWX Technologies, Inc. — Q3 2023 Form 10-Q Summary
Business context and reporting period
BWX Technologies, Inc. filed its unaudited Form 10-Q for the quarter and nine months ended September 30, 2023. The company operates through Government Operations, which serves U.S. naval nuclear, defense and Department of Energy programs, and Commercial Operations, which serves commercial nuclear, Canadian refurbishment and medical radioisotope markets.
Key financial metrics
| Metric | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
|---|---|---|---|---|
| Revenue | $590.0 million | $523.7 million | $1,770.8 million | $1,608.7 million |
| Operating income | $85.4 million | $79.9 million | $259.9 million | $246.7 million |
| Net income attributable to BWXT | $60.3 million | $61.6 million | $180.0 million | $195.2 million |
| Diluted EPS | $0.66 | $0.67 | $1.96 | $2.13 |
| Operating margin | 14.5% | 15.3% | 14.7% | 15.3% |
| Net margin attributable to BWXT | 10.2% | 11.8% | 10.2% | 12.1% |
Revenue increased 12.7% in the quarter and 10.1% year to date. Government Operations generated $477.9 million of third-quarter revenue and $85.6 million of operating income; Commercial Operations generated $112.4 million of revenue and $9.1 million of operating income.
For the nine months, net cash provided by operating activities was $141.9 million, compared with $137.0 million in the prior-year period. Capital expenditures were $100.5 million, compared with $134.6 million, producing negative investing cash flow of $105.0 million. Financing cash flow was negative $22.2 million, including $63.9 million of dividends paid and $50.3 million of net long-term debt borrowings. Total cash, cash equivalents and restricted cash were $56.2 million at September 30, 2023, including $50.2 million of unrestricted cash and cash equivalents.
Total debt consisted of $1.341 billion of current and long-term debt, compared with $1.289 billion at December 31, 2022. The company had $443.3 million of available borrowing capacity under its revolving credit facility, subject to applicable conditions. Working capital was $526.7 million at September 30, 2023, up from $403.8 million at year-end 2022.
Material changes versus the prior comparable period
- Government Operations revenue increased 13.1% in Q3 and 10.8% for the nine months, driven by naval nuclear fuel and uranium processing, nuclear component production and advanced technology design and engineering work.
- Commercial Operations revenue increased 10.4% in Q3 and 6.8% year to date, primarily from higher inspection, maintenance, modification and refurbishment activity and medical radioisotopes.
- Commercial Operations nine-month operating income declined $2.1 million, primarily because of project and product mix and $1.6 million of higher restructuring-related expenses.
- Unallocated corporate expenses increased $4.7 million in Q3 and $9.4 million year to date, primarily due to higher healthcare and compensation costs.
- Interest expense increased to $35.2 million for the nine months from $25.0 million, reflecting higher debt-related costs. Other net income declined to $9.5 million from $35.4 million, principally because prior-year results included substantially higher foreign-exchange derivative gains.
- Net favorable contract estimate changes increased Q3 revenue by $17.4 million and nine-month revenue by $4.4 million. A nuclear operations contract contributed favorable revenue adjustments of $20.4 million in Q3 and $20.0 million year to date, plus a $2.5 million reduction in cost of operations.
- Backlog declined to $3.981 billion from $4.144 billion at December 31, 2022. Government Operations backlog was $3.259 billion and Commercial Operations backlog was $722 million; approximately 57% is expected to be recognized by the end of 2024.
Guidance, outlook, risks and unusual items
The filing does not provide a specific quantitative revenue, earnings or cash-flow guidance range. Management states that it expects sufficient cash, operating cash generation, borrowing capacity and capital-market access to meet cash requirements for the next 12 months and beyond.
- The U.S. Government was operating under a continuing resolution through November 17, 2023, or until fiscal 2024 appropriations were enacted. Delays, a shutdown or changing defense priorities could delay awards, disrupt production or affect payments.
- Approximately $455.3 million of backlog was unfunded U.S. Government backlog. Approximately $200 million of unexercised options was excluded from backlog and is subject to annual appropriations.
- Contract profitability remains sensitive to labor costs, productivity, raw-material prices, schedule performance and estimates of costs to complete, particularly on fixed-price contracts.
- A DOE contract awarded to a joint venture was protested and returned to the DOE for reassessment. If re-awarded, transition would occur no earlier than the first half of 2024 and would require significant working-capital contributions during the first year.
- The company reported $113.6 million of outstanding surety bonds and $39.2 million of letters of credit under its bilateral facility, in addition to letters of credit under the revolving facility.
- Underfunded pension and postretirement obligations totaled approximately $73.1 million; expected contributions for the remainder of 2023 were approximately $2.7 million.
- Management reported no material contingencies during the period and no material changes to previously disclosed risk factors. Disclosure controls and procedures were deemed effective.
Important facts for investors to verify
- Confirm the status of fiscal 2024 U.S. Government appropriations and any effect on awards, unfunded backlog and program timing.
- Monitor conversion of the $3.981 billion backlog into revenue and cash, including the 57% expected through 2024.
- Assess whether favorable contract estimate adjustments, particularly the nuclear operations contract adjustment, are recurring or nonrecurring.
- Track leverage, interest expense, covenant compliance and borrowing capacity as debt costs remain elevated.
- Evaluate Commercial Operations’ margin recovery, project mix, restructuring costs and Canadian refurbishment activity.
- Review working-capital requirements associated with the protested DOE contract if it is re-awarded.